Scarica l'app Stockscreener
25.28
1.81%
0.45
Dopo l'orario di chiusura:
25.41
0.13
+0.51%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$24.83
Aprire:
$24.785
Volume 24 ore:
704.68K
Relative Volume:
0.91
Capitalizzazione di mercato:
$718.65M
Reddito:
$30.43M
Utile/perdita netta:
$-18.15M
Rapporto P/E:
-36.64
EPS:
-0.69
Flusso di cassa netto:
$-9.08M
1 W Prestazione:
-12.71%
1M Prestazione:
+137.37%
6M Prestazione:
+119.44%
1 anno Prestazione:
+111.02%
Intervallo 1D:
$24.20
$25.57
Intervallo di 1 settimana:
$23.81
$29.35
Portata 52W:
$9.76
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Nome
Clearpoint Neuro Inc
Settore
Industria
Telefono
(949) 900-6833
Indirizzo
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Confronta CLPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
25.28 | 739.97M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
127.63 | 231.95B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
97.78 | 142.60B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.25 | 141.45B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.04 | 123.83B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.65 | 43.07B | 5.69B | 1.41B | 577.90M | 6.9828 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-25 | Ripresa | B. Riley Securities | Buy |
| 2023-10-24 | Iniziato | Stifel | Buy |
| 2023-02-16 | Ripresa | B. Riley Securities | Buy |
| 2022-04-05 | Ripresa | B. Riley Securities | Buy |
| 2021-03-18 | Iniziato | Lake Street | Buy |
| 2020-07-17 | Iniziato | B. Riley FBR | Buy |
Mostra tutto
Clearpoint Neuro Inc Borsa (CLPT) Ultime notizie
Using economic indicators to assess ClearPoint Neuro Inc. potentialJuly 2025 Trends & Low Risk Growth Stock Ideas - newser.com
What momentum indicators show for ClearPoint Neuro Inc. stockMarket Activity Summary & Weekly High Return Stock Forecasts - newser.com
Will ClearPoint Neuro Inc. price bounce be sustainablePortfolio Profit Report & Community Supported Trade Ideas - newser.com
What margin trends mean for ClearPoint Neuro Inc. stockJuly 2025 PreEarnings & Long-Term Investment Growth Plans - newser.com
Can ClearPoint Neuro Inc. stock hit record highs againJuly 2025 Sentiment & Detailed Earnings Play Strategies - newser.com
Clearpoint Neuro Stock Forms Golden Cross, Signals Bullish Breakout Ahead - Markets Mojo
What the charts say about ClearPoint Neuro Inc. todayVolume Spike & Free Risk Controlled Daily Trade Plans - newser.com
Will earnings trigger a reversal in ClearPoint Neuro Inc.2025 Price Momentum & Verified Swing Trading Watchlists - newser.com
Tools to assess ClearPoint Neuro Inc.’s risk profileDip Buying & Short-Term Trading Alerts - newser.com
Will ClearPoint Neuro Inc. stock beat EPS estimatesJuly 2025 Technicals & Fast Momentum Stock Entry Tips - newser.com
ClearPoint Neuro (CLPT): Assessing Valuation Ahead of Upcoming Industry Conference Reveal - Sahm
ClearPoint Neuro (NASDAQ:CLPT) Sets New 1-Year HighTime to Buy? - MarketBeat
What’s next for ClearPoint Neuro Inc. stock priceEarnings Performance Report & Precise Swing Trade Entry Alerts - newser.com
Combining machine learning predictions for ClearPoint Neuro Inc.July 2025 PostEarnings & Reliable Price Breakout Alerts - newser.com
ClearPoint Neuro's (CLPT) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Clearpoint Neuro, Inc. Hits New 52-Week High of $29.85 - Markets Mojo
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Exploring Growth in the Medical Devices Sector - DirectorsTalk Interviews
ClearPoint Neuro (NASDAQ:CLPT) Trading Up 7.4%Should You Buy? - MarketBeat
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be presented at the CNS Annual Meeting in Los Angeles - MarketScreener
ClearPoint Neuro reports positive results from brain tumor laser therapy study - Investing.com Nigeria
ClearPoint Neuro reports positive results from brain tumor laser therapy study By Investing.com - Investing.com South Africa
ClearPoint Neuro Reports Phase I-II Study: Improved Survival | CLPT Stock News - Stock Titan
ClearPoint Neuro expands regulatory approvals to 34 countries - Investing.com India
ClearPoint Neuro expands regulatory approvals to 34 countries By Investing.com - Investing.com Nigeria
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide - ACCESS Newswire
34 Countries: ClearPoint Neuro Expands Regulatory Clearances with Canada, Hong Kong and Taiwan additions - Stock Titan
Clearpoint Neuro Reaches New 52-Week High of $28.80, Up 377% - Markets Mojo
CLPT Expands Into Robotic System Supporting Cell and Gene Therapies - The Globe and Mail
Will ClearPoint Neuro Inc. stock benefit from automationJuly 2025 Macro Moves & Reliable Price Breakout Signals - newser.com
Using RSI to spot recovery in ClearPoint Neuro Inc.Trade Volume Report & Real-Time Stock Price Movement Reports - newser.com
Using data models to predict ClearPoint Neuro Inc. stock movementSell Signal & Daily Growth Stock Investment Tips - newser.com
Will ClearPoint Neuro Inc. stock outperform value stocksQuarterly Market Review & Real-Time Stock Price Movement Reports - newser.com
Can ClearPoint Neuro’s (CLPT) New Robotic Platform Redefine Its Clinical Expansion Trajectory? - Sahm
ClearPoint Neuro (NASDAQ:CLPT) Reaches New 12-Month High – Here’s What Happened - Defense World
ClearPoint Neuro (CLPT): Gauging Valuation After Robotic Innovation, Insider Buying, and Huntington’s Therapy Progress - Yahoo Finance
Stifel maintains Clearpoint Neuro stock Buy rating, $17 target - MSN
ClearPoint Neuro (CLPT): Evaluating Valuation After Dr. Paul Larson Announced as Incoming Chief Medical Officer - Sahm
ClearPoint Neuro adds to gains, up 125% since Sept 23 - TradingView
ClearPoint Neuro (NASDAQ:CLPT) Hits New 52-Week HighHere's What Happened - MarketBeat
Clearpoint Neuro Inc Azioni (CLPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.23%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):